Alzheimer’s treatment with stem cells
The slow, progressive loss of brain function observed in Alzheimer’s disease (AD) has been associated to the appearance of plaques and tangles of neurofibrils within brain nerves that affect nerve synapses and nerve cell communication. This plaque formation has however never been fully explained until recent studies showed that bacteria are actually causing the inflammation that leads to these brain structural alterations.
Several types of bacteria have been found in the brain of patients suffering from AD. Spirochetes, the bacteria involved in Lyme disease, have been reported present in most of the patients. C. Pneumoniae were also detected in many. In studies published in 2013, bacteria involved in periodontitis were also reported in the brain of patients who suffered from AD. It is now clear that the slow brain degradation that leads to the symptoms of AD is due to a chronic infection.
The first important step to stop the progress of AD is therefore to address the chronic infection.
Depending on the results of the tests performed upon arrival, a course of natural anti-bacterial treatments will be offered that will be adapted to the patient’s needs. A specific diet may be recommended as well to help break the bacteria biofilms that are likely to be present after years of chronic infection.
Repairing Brain Functions
To date, it isn’t fully understood how Embryonic Stem Cells repair damaged brains but noticeable improvements are observed within days after ESC transplant.
It has been first speculated that ESC secrete growth factors that promote repair in the injured tissue. A recent study suggests that the transplanted stem cells actually create a matrix that bridges gaps between the site of injury and the region in the brain where neural stem cells naturally arise. Which ever causes the repair, new neural cells and new neuronal connections are created within days after ESC injections, leading to renewed brain capacity.
For patients suffering from AD, the improvements vary depending on the stage of the disease.
A minimum of 3 injections of 20 million ESC is recommended to observe significant changes.